| Code | 6679A | ||||||||||
| MA number | 09/0486/95-S | ||||||||||
| Product Form: | tbl ent 100x40 mg (blis.Al/Al-nem.bal.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | Takeda GmbH, Germany | ||||||||||
| Therapeutic Class: | 09 - ANTACIDA (VRÁTANE ANTIULCEROSNYCH LIEČIV) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - known active substance |
| MA issued: | 04.09.1995 |
| Validity: | 30.09.2000 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_CONTROLOC 40 mg_gastrorezistentne tablety_07_2023.pdf
|
| SPC: |
SPC_CONTROLOC 40 mg_gastrorezistentne tablety_07_2023.pdf
|
| Safety feature | Yes |
| Data update: | 04.05.2021 |
